MedTrace Logo

Improving Quality of Care With a Digital Behavioral Program in IBD Patient Centered Medical Home

NCT03186872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-01-09

No results posted yet for this study

Summary

Anxiety disorders and depression are more prevalent in patients living with inflammatory bowel disease (IBD) than in healthy controls. Approximately 40% of IBD patients have elevated anxiety. Given the robust effectiveness of cognitive behavioral approaches for anxiety disorders and the paucity or mixed findings of cognitive behavioral approaches for anxiety in IBD, an integrated behavioral approach and combining face to face and online cognitive behavioral modalities is recommended for IBD patients with anxiety.

Conditions

Interventions

BEHAVIORAL

Digital behavioral program app

mobile app utilizing cognitive behavioral techniques to help alleviate anxiety

Sponsors & Collaborators

  • Mount Sinai Hospital, New York

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Marc Schwartz, MD · University of Pittsburgh Medical Center

  • Eva Szigethy, MD, PhD · University of Pittsburgh Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2019-05-29
Completion
2019-05-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03186872 on ClinicalTrials.gov